Reaffirming revenue guidance, especially when it aligns with consensus estimates, can bolster investor confidence in the company's financial health and strategic direction. This alignment suggests that Organon is on track to meet market expectations, potentially leading to positive sentiment among investors and a favorable impact on the stock price in the short term.